ALTSTATION.IO

Brown & Brown, Inc. (BRO) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$73.45

Change

+1.07%

Market Cap

$25.08B

Avg Volume

2.7M

Company Overview

Brown & Brown, Inc. is a diversified insurance broker based in Daytona Beach, Florida. The company markets and sells a wide range of insurance products and services across the U.S., Canada, Ireland, the U.K., and other international markets. Their offerings span four main segments: Retail, Programs, Wholesale Brokerage, and Services. This includes property and casualty insurance, employee benefits, risk management, and third-party claims administration. Their clientele ranges from commercial organizations to individual customers, covering various professional sectors like dentistry, legal services, and real estate.

Brown & Brown holds a strong position as a market leader in the insurance brokerage sector. With a broad product portfolio and an extensive network of independent agents, they maintain a competitive edge. However, they face challenges from larger firms like Marsh & McLennan and Aon, which have more resources. Additionally, the insurance market is experiencing pressures from rising claims costs and regulatory changes, which can impact profitability.

Currently, Brown & Brown is in a growth phase. They have been expanding their footprint through strategic acquisitions and investments in technology to enhance their service offerings. Recent milestones include the acquisition of multiple regional firms, which has bolstered their market presence. Their focus on innovative insurance solutions suggests they’re positioning themselves for long-term success despite sector challenges.

Key Financials

Market Cap

$25.08B

Revenue

$5.76B

EBITDA

$1.87B

Gross Margin

49.1%

Profit Margin

18.3%

Revenue Growth

36.1%

Total Cash

$1.08B

Total Debt

$7.86B

Free Cash Flow

$1.38B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

23.24

Forward P/E

14.75

Beta

0.79

52-Week High

$125.68

52-Week Low

$70.45

EPS

$3.16

50-Day Avg

$78.65

200-Day Avg

$93.70

Price/Book

1.97

Technical Analysis

The stock chart for Brown & Brown, Inc. (BRO) indicates a clear downtrend over the past 52 weeks, marked by a significant decline of 31.8% and a peak around $120 in February, followed by a steady drop. Key resistance is established near the $110 level, which has been tested multiple times throughout the year but has failed to hold. Support levels are evident around $70, where the price has recently stabilized, suggesting a potential bottoming pattern. The recent momentum shows the stock has been trading sideways, reflecting a struggle to reclaim higher ground after reaching a low near the $70 support level. Currently priced at $73.45, BRO lies close to the lower end of its 52-week range, reinforcing bearish sentiment and indicating vulnerability to further declines if support levels fail to hold. Overall, the bearish trend remains dominant, and the stock’s position suggests a cautious outlook for potential reversal or recovery.

Recent News and Developments

Here’s a summary of the latest news and developments for Brown & Brown, Inc

(BRO) stock in the past week:

1. Investor Investigation Announced

Pomerantz LLP announced an investor investigation into Brown & Brown, Inc. on February 1, 2026. This investigation raises potential legal and settlement risks for the company and could put pressure on the stock while the probe is ongoing.

2. Multiple Analyst Price Target Reductions and Rating Adjustments

Several financial firms adjusted their outlooks on Brown & Brown (BRO) during the past week or just prior, with reports surfacing early in the week. Morgan Stanley lowered its price target for Brown & Brown to $78 from $85 on January 29th, maintaining an “equal weight” rating. BMO Capital Markets also reduced its price target to $81 from $88 on January 28th, placing a “market perform” rating on the stock. Mizuho followed suit, cutting its price target to $84 from $90 on January 27th, citing revenue headwinds. UBS similarly lowered its price target to $81 from $90. These coordinated revisions contributed to downward pressure on the stock.

Market Sentiment and Analyst Recommendations

Bull Case

Brown & Brown grew revenue 36.1% year-over-year, which is exceptional for an insurance broker. The company beat EPS estimates ($0.93 vs $0.91 consensus) and is projecting $30-40 million in synergies from the Accession integration in 2026, suggesting management can extract value from acquisitions. The margin guidance of 32%-37% indicates operating leverage coming online. At a 23.24 P/E with $1.08 billion in cash against $7.86 billion debt, the valuation isn’t cheap but isn’t outrageous for a consolidator with proven M&A execution. The stock is trading near $70 support after a 31.8% decline from its $125.68 peak, creating a potential entry point for investors who believe the recent selloff overreacted to analyst downgrades and the investor investigation.

Bear Case

Q4 revenue missed estimates ($1.61B vs $1.65B expected), signaling the growth narrative is cracking under pressure. Multiple analysts slashed targets in one week (Morgan Stanley to $78, BMO to $81, Mizuho to $84, UBS to $81), suggesting consensus is recalibrating lower on revenue headwinds that management hasn’t adequately addressed. The Pomerantz investor investigation adds legal risk and uncertainty that could drag on the stock for months. The company lost its Chief Legal Officer, Robert Mathis, introducing leadership uncertainty at a sensitive time. The debt load of $7.86 billion is substantial and constrains financial flexibility if the growth slowdown persists. The stock is down 41% from its February 2025 peak, and the bearish chart pattern with repeated failures at $110 resistance suggests institutional holders are exiting.

What to Watch

Monitor Q1 2026 revenue growth rates when earnings drop in April. If organic growth falls below 8-10%, the 36% headline number was acquisition-driven, not operational, and the margin guidance becomes suspect. Track the status of the Pomerantz investigation and any settlement announcements that could materialize in the next 60-90 days. Watch whether Eileen Akerson, the interim Chief Legal Officer, is promoted permanently or if the company recruits externally, which could signal confidence or concern about stability. The $70 support level is critical on the chart; a break below it targets $60-65 and confirms the downtrend. Accession synergy realization is quantifiable and should show up in Q1-Q2 margins; miss that number and the 32%-37% guidance is toast. Finally, track analyst target revisions over the next two weeks; if downgrades continue, the consensus $84.36 target will fall further, creating more downside pressure.

Analyst Consensus

HOLD

Based on 14 analyst opinions

Low Target

$73.00

Mean Target

$84.36

High Target

$100.00

Earnings and Financial Data

Sector

Financial Services

Industry

Insurance Brokers

Employees

23,000

Earnings & Dividends

Next Earnings

Jan 26, 2026

EPS (Trailing)

$3.16

Dividend Yield

87.0%

Payout Ratio

19.5%

Frequently Asked Questions

Is BRO a good stock to buy?

Currently, analysts recommend a HOLD on Brown & Brown, Inc. (BRO), with a target price of $84.36. The stock is trading at $73.45, which indicates some upside potential, but the market cap of $25.08B suggests it’s a large and perhaps more stable investment.

What is BRO’s price target?

The average analyst target price for BRO is $84.36. This represents a potential upside of about 14.8% from the current price of $73.45.

Does BRO pay a dividend?

Yes, BRO has a dividend yield of 87.0%. This is an attractive feature for income-focused investors, given that many stocks in the Financial Services sector offer lower yields.

How does BRO’s P/E ratio compare to the industry?

BRO’s P/E ratio is 23.24, while its forward P/E is 14.75. This suggests the stock is currently trading at a premium compared to future earnings projections, indicating cautious investor sentiment.

What is BRO’s 52-week trading range?

BRO has traded between $70.45 and $125.68 over the past 52 weeks. The current trading price of $73.45 is near the lower end of this range, suggesting it could be undervalued compared to its historical performance.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.